Fresh Recalls

FDAClass II · Drug · Recall D-0677-2026 · Recalled July 22, 2026

Nystatin Cream USP recall — Padagis US LLC

Agency report date: July 22, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Nystatin Cream USP
Company / brand
Padagis US
Lot / serial / date codes
Lot #: 205060, Exp 09/30/2027
Distribution
USA Nationwide
Agency product description and boundaries

Nystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, Israel, NDC 45802-059-35

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Subpotent Drug: Low out of specification assay results performed during long-term stability testing.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Nystatin Cream USP

3. Open the official notice or contact

Official recall ID
D-0677-2026
Brand
Padagis US
Classification
Class II
Units affected
180,936 tubes
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Minneapolis, MN, United States
Firm address
3940 Quebec Ave N, 55427-1244

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: 205060, Exp 09/30/2027
Distribution
USA Nationwide
Firm notified the public via
Letter
FDA event ID
99283
Recall initiated
June 23, 2026
FDA classified
July 13, 2026
FDA report date
July 22, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page